阿尔茨海默病与后皮质萎缩患者临床和影像学表现的梯度多维变异
本研究为横断面、单中心、观察性队列研究,纳入93例后皮质萎缩(PCA)患者和58例阿尔茨海默病(AD)患者,认知和脑体积指标经主成分分析提取维度,显示PCA与AD在共享表型连续体上呈梯度重叠变异,无类别样聚类。
要点
- PCA主成分分析提取3个维度,解释61.0%的认知表现方差。
- AD与PCA患者在多维空间和脑体积关系上呈梯度重叠,无类别样聚类。
- 结果支持将AD和PCA的临床与影像变异视为共享表型连续体上的系统性梯度变化。
核心结论
- 结果支持将异质性AD表型的临床和影像变异重新概念化为跨越PCA和AD的共享表型连续体,源于跨诊断多维神经认知几何中的系统性梯度变异。
研究设计与样本
- 横断面、单中心、观察性队列研究,在英国伦敦国家神经病学和神经外科医院进行。
- 纳入93例PCA患者(平均年龄59.9岁,MMSE 21.2,女性59/93)和58例AD患者(平均年龄57.1岁,MMSE 19.7,女性22/58),按年龄、病程和MMSE匹配。
- 结局包括22项神经心理学测验评分和高分辨率T1加权容积MRI扫描指标。
- 采用主成分分析提取表型变异维度,采用基于体素的形态学分析评估临床表型与结构测量的关联。
主要发现
- PCA的主成分分析样本 adequacy 确认(Kaiser-Meyer-Olkin=0.865),提取3个维度,解释患者表现61.0%的方差,反映一般认知损害、视知觉缺陷和视空间损害。
- 将AD病例映射到PCA衍生的多维空间及反之,显示病例沿这些维度呈梯度重叠变异,无类别样患者聚类证据。
- PCA和AD病例的脑体积与提取维度评分的关系同样重叠。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Alzheimer disease (AD) spans heterogeneous typical and atypical phenotypes. Posterior cortical atrophy (PCA) is a striking example, characterized by prominent impairment in visual and other posterior functions in contrast to typical, amnestic AD. The primary study objective was to establish how the similarities and differences of cognition and brain volumes within AD and PCA (and by extension other AD variants) can be conceptualized as systematic variations across a transdiagnostic, graded multidimensional space. METHODS: This was a cross-sectional, single-center, observational, cohort study performed at the National Hospital for Neurology & Neurosurgery, London, United Kingdom. Data were collected from a cohort of patients with PCA and AD, matched for age, disease duration, and Mini-Mental State Examination (MMSE) scores. There were 2 sets of outcome measures: (1) scores on a neuropsychological battery containing 22 tests spanning visuoperceptual and visuospatial processing, episodic memory, language, executive functions, calculation, and visuospatial processing and (2) measures extracted from high-resolution T1-weighted volumetric MRI scans. Principal component analysis was used to extract the transdiagnostic dimensions of phenotypical variation from the detailed neuropsychological data. Voxel-based morphometry was used to examine associations between the PCA-derived clinical phenotypes and the structural measures. RESULTS: We enrolled 93 participants with PCA (mean: age = 59.9 years, MMSE = 21.2; 59/93 female) and 58 AD participants (mean: age = 57.1 years, MMSE = 19.7; 22/58 female). The principal component analysis for PCA (sample adequacy confirmed: Kaiser-Meyer-Olkin = 0.865) extracted 3 dimensions accounting for 61.0% of variance in patients' performance, reflecting general cognitive impairment, visuoperceptual deficits, and visuospatial impairments. Plotting AD cases into the PCA-derived multidimensional space, and vice versa, revealed graded, overlapping variations between cases along these dimensions, with no evidence for categorical-like patient clustering. Similarly, the relationship between brain volumes and scores on the extracted dimensions was overlapping for PCA and AD cases. DISCUSSION: These results provide evidence supporting a reconceptualization of clinical and radiologic variation in these heterogenous AD phenotypes as being along shared phenotypic continua spanning PCA and AD, arising from systematic graded variations within a transdiagnostic, multidimensional neurocognitive geometry.
引用
- Ingram RU, Ocal D, Halai A, et al. Graded Multidimensional Clinical and Radiologic Variation in Patients With Alzheimer Disease and Posterior Cortical Atrophy. Neurology. 2024. PMID: 39042846. doi:10.1212/WNL.0000000000209679
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。